Cite

HARVARD Citation

    Reck, M. et al. (n.d.). 3093 Veliparib with carboplatin and paclitaxel: factors predictive of favorable outcomes in NSCLC. European journal of cancer. pp. S630-. [Online]. 
  
Back to record